Better Health for All

Bio-Rad's core business in life science research and clinical diagnostics, including products for disease detection, monitoring, and the preventative ColoSense colorectal cancer screening test, indicates that health impact is central to its business strategy

, . The company exhibits excellent risk transparency through a comprehensive privacy policy , an ethics helpline , and proactive communication during a Class 2 recall of a diagnostic kit in February 2024 . This recall, however, represents a notable safety incident due to potential inaccurate results . Bio-Rad demonstrates industry-leading healthcare data responsibility with robust safeguards , industry-standard encryption , user rights , and a dedicated Data Privacy Office . Its healthcare education initiatives are pioneering, reaching over 1 million students in 79 countries and training nearly 3,000 educators annually . The company also provides substantial healthcare workforce support by addressing lab staff burnout and offering professional development and education assistance to employees and educators , .

Fair Money & Economic Opportunity

Bio-Rad Laboratories operates in the life science research and clinical diagnostics markets, providing instruments, software, and consumables.

The company's core business does not involve offering lending, deposit, or other financial services to consumers. Therefore, all Key Performance Indicators related to fair money and economic opportunity, which are designed for financial institutions, are not applicable to Bio-Rad Laboratories.

Fair Pay & Worker Respect

In 2024, Bio-Rad Laboratories' CEO to median employee pay ratio was 108:1.

The CEO's total compensation was $8,289,471, while the median employee earned $76,818.

Honest & Fair Business

Bio-Rad Laboratories enhanced its anti-corruption policies globally, improved internal controls, and developed FCPA compliance procedures, which included due diligence and contracting for intermediaries.

The company also conducted extensive anti-corruption training. The Department of Justice (DOJ) and the Securities and Exchange Commission (SEC) commended Bio-Rad for its cooperation, internal investigation, remedial actions, and compliance enhancements.

Kind to Animals

Bio-Rad Laboratories has 40% of its products, including B2B lines, certified as cruelty-free.

The company uses approximately 1,500 animals per year for testing. Its animal testing policy is not fully transparent, and exemptions may exist for legacy compounds. Bio-Rad actively produces and uses thousands of non-animal derived antibodies for its products and customers, with these methods endorsed as suitable replacements for animal-derived antibodies. The company collaborates with XCellR8 to develop animal-free tests using its HuCAL technology and works with AFABILITY to accelerate the replacement of animals in scientific research. Additionally, Bio-Rad partners with World Land Trust, which has resulted in over 3,500 trees planted and over four acres reforested in the Atlantic Forest of Brazil.

No War, No Weapons

No specific, quantifiable evidence was found in the provided articles for any of the KPIs related to the 'No War, No Weapons' ethical value. While Bio-Rad Laboratories states a policy prohibiting sales to embargoed countries and for weapons development, and employs a Director of Global Trade Compliance,

the articles do not provide concrete data on the volume or frequency of sales, the specific mechanisms of control (e.g., automated systems), or verified outcomes (e.g., zero sales). Similarly, no evidence was found regarding dual-use technology, peacebuilding investment, conflict divestment, or other relevant metrics.

Planet-Friendly Business

Bio-Rad Laboratories sources 10% of its operational energy consumption from renewables.

The company reduced Scope 1 and 2 emissions at its North American and European sites from 2019 to 2023 and validated past emissions data going back to 2019. Bio-Rad implemented a beneficial reuse program for IR acetone solvent, which eliminated a hazardous waste stream and reduced a production facility's generator status from large-quantity to medium-quantity. The company is moving to recycled boxes and paper fillers for packaging. Additionally, Bio-Rad customers have helped plant over 3,500 trees in Brazil’s Atlantic Forest by switching to digital ordering.

Respect for Cultures & Communities

The company has 5 formal partnerships with organizations such as InnovATEBIO, Advance CTE, National Consortium of Health Science Educators, HOSA Future Health Professionals, and the SMILE Foundation.

No cultural appropriation incidents were reported. Free, Prior, and Informed Consent (FPIC) processes are not applicable to the company's operations as no projects involving indigenous communities were discussed.

Safe & Smart Tech

The company reported no incidents of unauthorized data use, and no evidence of unauthorized access, transfer, or misuse of data or personal information was found during a ransomware attack detected on December 5, 2019.

Compliance with relevant regulations is part of its enterprise risk management program, overseen by a Legal and Regulatory Compliance Committee, with no regulatory actions or violations mentioned. A vulnerability management program exists, utilizing NIST and CIS frameworks, and includes a vulnerability disclosure program. Security testing is conducted, using external service providers where appropriate, and cybersecurity awareness training is provided to employees.

Zero Waste & Sustainable Products

Bio-Rad reduced hazardous waste generation.

The company also had a 2010 goal to reuse chemicals within its manufacturing process. Bio-Rad provides self-service instructions for product disposal and recycling. No waste disposal violations were mentioned in articles from 2025-2026.